High Expression of Cathepsin E is Associated with the Severity of Airflow Limitation in Patients with COPD
High Expression of Cathepsin E is Associated with the Severity of Airflow Limitation in Patients with COPD
复制标题
组织蛋白酶 E 的高表达与 COPD 患者气流受限的严重程度相关
DOI:
10.3109/15412555.2015.1057273
复制
发表时间:
2016-03-03
影响因子:
2.2
通讯作者:
Xu, Jin-Fu
中科院分区:
文献类型:
--
作者:
Cao, Wei-Jun;Li, Man-Hui;Xu, Jin-Fu
Background: It was reported that Cathepsin E (Cat E) plays a critical role in antigen processing and in the development of pulmonary emphysema. The aim of this study was to investigate the role of Cat E and airflow limitation in the pathogenesis of COPD. Methods: Sixty-five patients with COPD, 20 smoking control subjects without COPD and 15 non-smoking healthy control subjects were enrolled. Cat E and EIC (Elastase inhibitory capacity) expressions were measured by ELISA in sputum and serum samples and compared according to different subgroups. Results: Cat E concentrations were significantly higher in patients with COPD than smoking control and non-smoking control subjects (P < 0.01). The levels of CatE were inversely correlated with FEV1% predicted in COPD patients (r = -0.95, P < 0.01). The levels of EIC were inversely positively correlated with FEV1% predicted in COPD patients (r = 0.926, P < 0.01). Levels of Cat E were also inversely correlated with the levels of EIC (r = -0.922, P < 0.01). Conclusions: Cat E contributes to the severity of airflow limitation during progression of COPD.